Biolife Solutions (BLFS) Net Shares Issued and Repurchased (2012 - 2023)

Biolife Solutions (BLFS) has reported Net Shares Issued and Repurchased for 8 consecutive years, with $268738.0 the latest figure, recorded in Q1 2023.

• On a quarterly basis, Net Shares Issued and Repurchased fell 23.12% year-over-year to $268738.0 in Q1 2023; TTM through Mar 2023 was $268738.0, a 23.12% decrease from a year earlier, with the FY2022 full-year figure at $1.4 million, up 71.42% from the prior year.
• Net Shares Issued and Repurchased was $268738.0 for Q1 2023 at Biolife Solutions, down from $1.4 million in the prior quarter.
• Over five years, Net Shares Issued and Repurchased peaked at $1.4 million in Q4 2022 and troughed at $268738.0 in Q1 2023.
• A 3-year average of $698424.8 and a median of $575526.0 in 2021 frame the typical range for Net Shares Issued and Repurchased.
• Across the five-year window, Net Shares Issued and Repurchased jumped 71.42% in 2022 and retreated 23.12% in 2023, its largest moves.
• Over 3 years, Net Shares Issued and Repurchased stood at $801484.0 in 2021, then jumped by 71.42% to $1.4 million in 2022, then slumped by 80.44% to $268738.0 in 2023.
• The last three Net Shares Issued and Repurchased figures came in at $268738.0 (Q1 2023), $1.4 million (Q4 2022), and $349568.0 (Q1 2022), per Business Quant data.